ebomi
The catalogIssuersInsidersTapeLicence
Colour theme
Theme
Sign in
Insider · CIK 0001413378

Viking Global Equities II LP

CIK 0001413378 Name as filed on the most recent filing

Filed as Viking Global Equities II LP (24)

64 transaction lines · from 24 filings · filed 2014-10-06 to 2024-06-18 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2024-06-17 APi Group Corp
APG 		S, Open-market sale 1,912,750 disposed 38.15 72,971,412.50 Form 4, filing 0000905148-24-001732
2024-06-17 APi Group Corp
APG 		S, Open-market sale 39,032 disposed 38.15 1,489,070.80 Form 4, filing 0000905148-24-001732
2024-03-05 APi Group Corp
APG 		S, Open-market sale 2,977,845 disposed 34.25 101,991,191.25 Form 4, filing 0000905148-24-000919
2024-03-05 APi Group Corp
APG 		S, Open-market sale 60,772 disposed 34.25 2,081,441.00 Form 4, filing 0000905148-24-000919
2024-01-02 APi Group Corp
APG 		S, Open-market sale 6,300,817 disposed 31.30 197,215,572.10 Form 4, filing 0000905148-24-000079
2024-01-02 APi Group Corp
APG 		S, Open-market sale 195,200 disposed 31.30 6,109,760.00 Form 4, filing 0000905148-24-000079
2024-01-02 APi Group Corp
APG 		S, Open-market sale 3,983 disposed 31.30 124,667.90 Form 4, filing 0000905148-24-000079
2023-06-22 Roivant Sciences Ltd.
ROIV 		S, Open-market sale 5,427,043 disposed 9.90 53,727,725.70 Form 4, filing 0001140361-23-031456
2023-06-22 Roivant Sciences Ltd.
ROIV 		S, Open-market sale 5,236,006 disposed 9.90 51,836,459.40 Form 4, filing 0001140361-23-031456
2023-06-22 Roivant Sciences Ltd.
ROIV 		S, Open-market sale 2,226,195 disposed 9.90 22,039,330.50 Form 4, filing 0001140361-23-031456
2023-06-22 Roivant Sciences Ltd.
ROIV 		S, Open-market sale 110,756 disposed 9.90 1,096,484.40 Form 4, filing 0001140361-23-031456
2020-12-14 Adaptive Biotechnologies Corp
ADPT 		S, Open-market sale 1,000,000 disposed 55.65 55,650,000.00 Form 4, filing 0001387131-20-011164
2020-11-11 Adaptive Biotechnologies Corp
ADPT 		S, Open-market sale 2,500,000 disposed 49.52 123,787,500.00 Form 4, filing 0001387131-20-009936
2020-01-28 Adaptive Biotechnologies Corp
ADPT 		S, Open-market sale 4,912,899 disposed 24.98 122,706,039.29 Form 4, filing 0000903423-20-000011
2019-06-19 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 4,957 acquired 8.17 40,495.22 Form 4, filing 0000903423-19-000253
2019-06-18 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 6,706 acquired 8.21 55,060.95 Form 4, filing 0000903423-19-000253
2019-06-17 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 6,541 acquired 8.53 55,824.82 Form 4, filing 0000903423-19-000253
2019-06-14 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 7,144 acquired 7.91 56,514.04 Form 4, filing 0000903423-19-000248
2019-06-13 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 7,367 acquired 7.95 58,542.60 Form 4, filing 0000903423-19-000248
2019-06-12 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 7,500 acquired 8.30 62,244.00 Form 4, filing 0000903423-19-000248
2019-06-11 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 7,189 acquired 8.58 61,693.84 Form 4, filing 0000903423-19-000241
2019-06-10 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 7,500 acquired 8.35 62,594.25 Form 4, filing 0000903423-19-000241
2019-06-07 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 6,649 acquired 7.96 52,959.28 Form 4, filing 0000903423-19-000241
2019-06-06 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 7,082 acquired 8.00 56,621.30 Form 4, filing 0000903423-19-000239
2019-06-05 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 6,540 acquired 8.02 52,418.10 Form 4, filing 0000903423-19-000239
2019-06-04 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 7,500 acquired 7.59 56,910.75 Form 4, filing 0000903423-19-000239
2019-06-04 Myovant Sciences Ltd.
MYOV 		P, Open-market purchase 2,424,242 acquired 8.25 19,999,996.50 Form 4, filing 0000903423-19-000244
2019-06-03 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 5,424 acquired 7.71 41,814.70 Form 4, filing 0000903423-19-000237
2019-05-31 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 5,071 acquired 7.70 39,042.14 Form 4, filing 0000903423-19-000237
2019-05-30 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 6,951 acquired 7.97 55,417.54 Form 4, filing 0000903423-19-000237
2019-05-30 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 300 acquired 8.91 2,671.98 Form 4, filing 0000903423-19-000237
2019-05-29 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 6,882 acquired 7.55 51,983.19 Form 4, filing 0000903423-19-000233
2019-05-28 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 3,807 acquired 7.68 29,244.61 Form 4, filing 0000903423-19-000233
2019-05-24 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 3,796 acquired 7.70 29,233.38 Form 4, filing 0000903423-19-000233
2019-05-23 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 4,802 acquired 7.76 37,252.00 Form 4, filing 0000903423-19-000228
2019-05-22 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 5,033 acquired 8.06 40,557.93 Form 4, filing 0000903423-19-000228
2019-05-21 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 9,995 acquired 8.52 85,108.42 Form 4, filing 0000903423-19-000228
2019-05-20 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 8,285 acquired 7.98 66,141.64 Form 4, filing 0000903423-19-000224
2019-05-20 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 1,715 acquired 8.39 14,383.19 Form 4, filing 0000903423-19-000224
2019-05-17 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 6,200 acquired 7.36 45,641.30 Form 4, filing 0000903423-19-000224
2019-05-16 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 5,408 acquired 6.79 36,718.16 Form 4, filing 0000903423-19-000224
2019-03-18 Axovant Sciences Ltd.
AXON 		P, Open-market purchase 6,666,667 acquired 1.50 10,000,000.50 Form 4, filing 0000903423-19-000152
2018-12-18 Axovant Sciences Ltd.
AXON 		P, Open-market purchase 10,000,000 acquired 1.00 10,000,000.00 Form 4, filing 0000903423-18-000641
2018-10-01 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 2,678,571 acquired 14.00 37,499,994.00 Form 4, filing 0000903423-18-000528
2018-06-05 Axovant Sciences Ltd.
AXON 		P, Open-market purchase 14,285,714 acquired 1.75 24,999,999.50 Form 4, filing 0000903423-18-000325
2018-04-02 Myovant Sciences Ltd.
MYOV 		P, Open-market purchase 1,110,015 acquired 20.27 22,500,004.05 Form 4, filing 0000903423-18-000191
2015-02-08 Editas Medicine, Inc.
EDIT 		P, Open-market purchase 20,407 acquired Not reported Not priced Form 4, filing 0000903423-16-000809
2015-02-08 Editas Medicine, Inc.
EDIT 		P, Open-market purchase 15,072 acquired Not reported Not priced Form 4, filing 0000903423-16-000809
2015-02-08 Editas Medicine, Inc.
EDIT 		P, Open-market purchase 481,567 acquired Not reported Not priced Form 4, filing 0000903423-16-000809
2015-02-08 Editas Medicine, Inc.
EDIT 		P, Open-market purchase 261,447 acquired Not reported Not priced Form 4, filing 0000903423-16-000809

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. Viking Global Equities II LP, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001413378

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.